Medical Research Future Fund

The Medical Research Future Fund (MRFF) is a $20 billion vehicle for investment in health and medical research. It represents the single largest boost to research funding in Australia’s history. It will support research and innovation activities with the objective of improving the health and wellbeing of Australians.

  • What is the MRFF?
  • Programs funded to date

    The MRFF provides medical research funding via partner agencies that run peer review funding programs. It is not possible to apply directly to the MRFF for funding. For example, the MRFF has already partnered with the NHMRC, CanTeen and The Cure for MND Foundation. The University of Melbourne regularly monitor programs announced by the MRFF to provide support for applicants as call for applications emerge. Details of available support and internal submission procedures will be posted on Research Professional

    First disbursements from the Medical Research Future Fund

    BioMedTech Horizons Expressions of Interest Now Open – MRFF funding via MTPConnect

    **Update - Stage 2 application form (Stage 2 shortlisted applicants only) - Due 15 January 2018 - 5pm AEST

    Expressions of Interest (EOIs) are open for the Australian Government's $5 million BioMedTech Horizons program, an initiative to support innovative collaborative health technologies that address key health challenges. MTPConnect is delivering this grant program on behalf of the Australian Government as part of the $20 billion Medical Research Future Fund.

    MTPConnect welcomes ideas that are set to customise and revolutionise healthcare, stimulate inter-disciplinary collaboration between research, industry and technology sectors, and foster strong entrepreneurship potential.

    Investments from the program will be focused on supporting cutting-edge ideas in precision medicine and 3D anatomical printing towards proof-of-concept and commercialisation. Innovative technologies in these areas can play a key role in significantly transforming the national healthcare system and promote Australia's international ranking as a leader in biotechnology and medical technology.

    Approximately $3 million is reserved for supporting ideas in precision medicine and $2 million for ideas in the 3D anatomical printing area. Up to $1 million is offered in funding for individual projects over the next two years, to drive innovation and foster commercialisation. Cash and/or in-kind contributions from the applicant will be viewed favourably.

    Important Dates:

    • Expressions of interest open: 1 November 2017
    • Closing date for EOI: 10 December 2017
    • Closing date for stage 2 applications: 15 January 2018
    • Announcement of successful applications: expected late February 2018

    RIC Contact: Sophie Cleaves,

  • Strategy and Priorities
  • More information and contacts

    Research Australia MRFF
    Department of Health MRFF

    For general enquiries and requests for coordinating information sessions, please contact:

    Frank Anastasopoulos
    Acting Director - Major Initiatives, Contracts and Grants
    T: +61 3 8344 8208 M: +61 424 004 794

    Or email the MRFF enquiries mailbox